Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose‐Driven Approach
Open Access
- 20 January 2024
- journal article
- review article
- Published by Wiley in Movement Disorders
- Vol. 39 (3) , 462-471
Abstract
The International Parkinson and Movement Disorder Society (MDS) created a task force (TF) to provide a critical overview of the Parkinson's disease (PD) subtyping field and develop a guidance on future research in PD subtypes. Based on a literature review, we previously concluded that PD subtyping requires an ultimate alignment with principles of precision medicine, and consequently novel approaches were needed to describe heterogeneity at the individual patient level. In this manuscript, we present a novel purpose‐driven framework for subtype research as a guidance to clinicians and researchers when proposing to develop, evaluate, or use PD subtypes. Using a formal consensus methodology, we determined that the key purposes of PD subtyping are: (1) to predict disease progression, for both the development of therapies (use in clinical trials) and prognosis counseling, (2) to predict response to treatments, and (3) to identify therapeutic targets for disease modification. For each purpose, we describe the desired product and the research required for its development. Given the current state of knowledge and data resources, we see purpose‐driven subtyping as a pragmatic and necessary step on the way to precision medicine. © 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.Keywords
This publication has 53 references indexed in Scilit:
- Critical Values for Lawshe’s Content Validity RatioMeasurement and Evaluation in Counseling and Development, 2014
- Influence of Single Nucleotide Polymorphisms in COMT, MAO-A and BDNF Genes on Dyskinesias and Levodopa Use in Parkinson's DiseaseNeurodegenerative Diseases, 2013
- Rapid eye movement sleep behavior disorder and subtypes of Parkinson's diseaseMovement Disorders, 2012
- Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: A prospective studyMovement Disorders, 2012
- Catechol‐O‐methyltransferase Val158Met and the risk of dyskinesias in Parkinson's diseaseMovement Disorders, 2011
- The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: A randomized crossover clinical trialAnnals of Neurology, 2010
- Histological, molecular and functional subtypes of breast cancersCancer Biology & Therapy, 2010
- Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patientsBrain, 2009
- A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attackThe Lancet, 2005
- The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1988